Log in to save to my catalogue

Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight

Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2678428717

Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight

About this item

Full title

Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Gastroenterology & hepatology, 2022-10, Vol.19 (10), p.638-651

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Metabolic (dysfunction)-associated fatty liver disease (MAFLD) affects up to a third of the global population; its burden has grown in parallel with rising rates of type 2 diabetes mellitus and obesity. MAFLD increases the risk of end-stage liver disease, hepatocellular carcinoma, death and liver transplantation and has extrahepatic consequences, i...

Alternative Titles

Full title

Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2678428717

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2678428717

Other Identifiers

ISSN

1759-5045

E-ISSN

1759-5053

DOI

10.1038/s41575-022-00635-5

How to access this item